These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 3171632)
21. Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer. Ma CD; Chen CM; Chen XS; Liu GY; Di GH; Wu J; Lu JS; Yang WT; Chen JY; Shao ZM; Shen ZZ; Shen KW Anticancer Res; 2008; 28(5B):3093-7. PubMed ID: 19031963 [TBL] [Abstract][Full Text] [Related]
22. [Neoadjuvant chemotherapy for primary breast cancer]. Li JF; Ouyang T; Wang TF; Lin BY Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):493-5. PubMed ID: 15555342 [TBL] [Abstract][Full Text] [Related]
23. Taxoids in combination with epirubicin: the search for improved outcomes in breast cancer. Pagani O Semin Oncol; 1998 Oct; 25(5 Suppl 12):23-6. PubMed ID: 9865708 [TBL] [Abstract][Full Text] [Related]
24. Is radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy? Daveau C; Savignoni A; Abrous-Anane S; Pierga JY; Reyal F; Gautier C; Kirova YM; Dendale R; Campana F; Fourquet A; Bollet MA Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1452-9. PubMed ID: 20605368 [TBL] [Abstract][Full Text] [Related]
25. Epirubicin in combination with the taxanes. Trudeau M; Pagani O Semin Oncol; 2001 Aug; 28(4 Suppl 12):41-50. PubMed ID: 11552229 [TBL] [Abstract][Full Text] [Related]
26. Landmark study demonstrates survival benefit at 10 years for breast cancer patients. Oncology (Williston Park); 2003 Mar; 17(3):387. PubMed ID: 12661270 [No Abstract] [Full Text] [Related]
27. Adjuvant chemotherapy for breast cancer--30 years later. Levine MN; Whelan T N Engl J Med; 2006 Nov; 355(18):1920-2. PubMed ID: 17079767 [No Abstract] [Full Text] [Related]
28. [Intra-arterial infusion chemotherapy in the treatment of advanced breast cancer--doxorubicin versus epirubicin]. Yayoi E; Furukawa J; Takatsuka Y; Kobayashi T; Aikawa T; Maeura Y; Kaji M; Kotsuma Y Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1621-4. PubMed ID: 1530320 [TBL] [Abstract][Full Text] [Related]
29. Epirubicin, alone or in combination chemotherapy, for metastatic breast cancer. Provincial Breast Cancer Disease Site Group and the Provincial Systemic Treatment Disease Site Group. Findlay BP; Walker-Dilks C Cancer Prev Control; 1998 Jun; 2(3):140-6. PubMed ID: 10093625 [TBL] [Abstract][Full Text] [Related]
30. Epirubicin and cyclophosphamide followed by docetaxel as primary systemic chemotherapy in locally advanced breast cancer. Hirano A; Shimizu T; Watanabe O; Kinoshita J; Kimura K; Kamimura M; Domoto K; Aiba M; Ogawa K Anticancer Res; 2008; 28(6B):4137-42. PubMed ID: 19192673 [TBL] [Abstract][Full Text] [Related]
31. Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet). Leonard RC; Williams S; Tulpule A; Levine AM; Oliveros S Breast; 2009 Aug; 18(4):218-24. PubMed ID: 19656681 [TBL] [Abstract][Full Text] [Related]
32. Cytoxan, epirubicin, methotrexate and 5-fluorouracil with hormonal synchronization (tamoxifen/premarin) in advanced breast cancer. Preliminary results. Zaniboni A; Simoncini E; Marpicati P; Gorni F; Cervi GC; Marini G Chemioterapia; 1986 Oct; 5(5):341-6. PubMed ID: 3024851 [TBL] [Abstract][Full Text] [Related]
33. Primary chemotherapy with epirubicin and vinorelbine in women with locally advanced breast cancer. Nisticò C; De Matteis A; Rossi E; Carnino F; Valenza R; Agostara B; Bria E; Farris A; Cremonesi M; D'Ottavio AM; Vaccaro A; Garufi C; Giunta S; Botti C; Perrone F; Terzoli E Anticancer Res; 2005; 25(2B):1343-8. PubMed ID: 15865089 [TBL] [Abstract][Full Text] [Related]
34. Adjuvant therapy for early breast cancer. Costa SD; Bischoff J N Engl J Med; 2007 Mar; 356(12):1268-9. PubMed ID: 17377168 [No Abstract] [Full Text] [Related]
35. High pathologic complete response in HER 2-positive locally advanced breast cancer after primary systemic chemotherapy with weekly docetaxel and epirubicin. Chen SC; Chang HK; Lin YC; Hsueh S; Cheung YC; Leung WM; Tsai CS; Lo YF; Tsai HP; Shen SC; Chen MF Jpn J Clin Oncol; 2008 Feb; 38(2):99-105. PubMed ID: 18270380 [TBL] [Abstract][Full Text] [Related]
36. A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group. J Clin Oncol; 1988 Apr; 6(4):679-88. PubMed ID: 2895801 [TBL] [Abstract][Full Text] [Related]
37. Dose-response relationship of epirubicin-based first-line chemotherapy for advanced breast cancer: a prospective randomized trial. Focan C; Andrien JM; Closon MT; Dicato M; Driesschaert P; Focan-Henrard D; Lemaire M; Lobelle JP; Longree L; Ries F J Clin Oncol; 1993 Jul; 11(7):1253-63. PubMed ID: 8315422 [TBL] [Abstract][Full Text] [Related]
38. [Intra-arterial infusion chemotherapy for advanced or recurrent breast cancers]. Okazaki M; Okazaki A; Masuoka H; Toda K; Yamada T; Okazaki Y; Asaishi K; Hirata K; Narimatsu E Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():94-101. PubMed ID: 7747999 [TBL] [Abstract][Full Text] [Related]
39. Cytokinetic-based versus conventional chemotherapy in metastatic breast cancer: a randomized study. Conte PF; Rubagotti A; Falcone A; Gardin G; Nicolin A; Pronzato P; Rosso R; Amadori D; Gentilini P; Sismondi P Chemioterapia; 1987 Jun; 6(2 Suppl):712-3. PubMed ID: 3334664 [No Abstract] [Full Text] [Related]
40. [Neoadjuvant chemotherapy for locally advanced breast cancer]. Takatsuka Y Nihon Rinsho; 2000 Apr; 58 Suppl():209-14. PubMed ID: 11025997 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]